SCHEMBL19639

SCHEMBL19639

CCCOC(=O)CCCC(=O)O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.57
TSHR P16473 5/20 0.56
PAM P19021 2/20 0.52
AKR1B1 P15121 1/20 0.50
GPR84 Q9NQS5 7/20 0.48
PPARG P37231 7/20 0.48
PPARD Q03181 7/20 0.48
PPARA Q07869 7/20 0.48
HDAC11 Q96DB2 5/20 0.48
PTPN1 P18031 3/20 0.48
ALDH1A1 P00352 2/20 0.48
TLR2 O60603 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
FABP4 P15090 2/20 0.48
SLC22A6 Q4U2R8 2/20 0.48
SLC22A8 Q8TCC7 1/20 0.48
MEN1 O00255 1/20 0.48
ESR1 P03372 1/20 0.48
ALOX15 P16050 1/20 0.48
PDE4A P27815 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10550073 0.98 DGKA (0.55) DGKATSHRPAMAKR1B1GPR84
Glutarate SCHEMBL28197350 0.96 DGKA (0.59) DGKATSHRPAMAKR1B1GPR84
SCHEMBL1419216 0.96 DGKA (0.63) DGKATSHRPAMAKR1B1GPR84
SCHEMBL27586249 0.94 DGKA (0.67) DGKATSHRPAMAKR1B1GPR84
SCHEMBL3446767 0.94 DGKA (0.67) DGKATSHRPAMAKR1B1GPR84
SCHEMBL3447479 0.94 DGKA (0.67) DGKATSHRPAMAKR1B1GPR84
SCHEMBL3446796 0.94 DGKA (0.67) DGKATSHRPAMAKR1B1GPR84
SCHEMBL4994992 0.94 DGKA (0.67) DGKATSHRPAMAKR1B1GPR84
Hexanoate SCHEMBL7031339 0.92 DGKA (0.70) DGKATSHRPAMAKR1B1GPR84
Acetic Acid SCHEMBL28276583 0.92 DGKA (0.59) DGKATSHRPAMAKR1B1GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103554312-B A kind of internal electron donor compound for preparing alpha-olefin polymerization catalyst component 营口市向阳催化剂有限责任公司 2016-08-17 CN claimed
CN-103554312-A Internal electron donor compound for preparing alpha-olefin polymerization catalyst component YINGKOU XIANGYANG CATALYST CO LTD 2014-02-05 CN claimed
US-7060301-B2 In situ mono-or diester dicarboxylate compositions ECOLAB INC. (US) 2006-06-13 US claimed
US-20030021853-A1 In situ mono-or diester dicarboxylate compositions ECOLAB USA INC. 2003-01-30 US claimed
WO-2003005818-A1 IN SITUMONO-OR DIESTER DICARBOXYLATE COMPOSITIONS ECOLAB INC. (US) 2003-01-23 WO claimed
EP-4368686-B1 LUBRICITY IMPROVER COMPOSITION FOR FUEL OIL AND USE THEREOF CHINA PETROLEUM & CHEM CORP (CN) 2026-05-27 EP disclosed
US-12365847-B2 Lubricity improver composition for fuel oil and use thereof CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2025-07-22 US disclosed
US-20240368490-A1 LUBRICITY IMPROVER COMPOSITION FOR FUEL OIL AND USE THEREOF Sinopec Research Institute of Petroleum Processing Co., Ltd. (CN) 2024-11-07 US disclosed
EP-4368686-A1 LUBRICITY IMPROVER COMPOSITION FOR FUEL OIL AND USE THEREOF China Petroleum & Chemical Corporation (CN) 2024-05-15 EP disclosed
CN-118028391-A Preparation method of S-configuration monoamide compound and brivaracetam intermediate 北京泛球生物科技有限公司 2024-05-14 CN disclosed
CN-118028391-A Preparation method of S-configuration monoamide compound and brivaracetam intermediate 北京泛球生物科技有限公司 2024-05-14 CN disclosed
CN-115141661-B Jet fuel composition and method for improving jet fuel lubricity 中国石油化工股份有限公司 2024-01-05 CN disclosed
US-20030021853-A1 In situ mono-or diester dicarboxylate compositions ECOLAB USA INC. 2003-01-30 US disclosed
WO-2003005817-A2 HIGH CONCENTRATION MONOESTER PEROXY DICARBOXYLIC ACID COMPOSITIONS, USE SOLUTIONS, AND METHODS EMPLOYING THEM ECOLAB INC. (US) 2003-01-23 WO disclosed
WO-2003005818-A1 IN SITUMONO-OR DIESTER DICARBOXYLATE COMPOSITIONS ECOLAB INC. (US) 2003-01-23 WO disclosed
WO-2002088076-A2 STABILIZED ESTER PEROXYCARBOXYLIC ACID COMPOSITIONS ECOLAB INC. (US) 2002-11-07 WO disclosed
US-20020128312-A1 Adding a C2 or higher alcohol as a stabilizer ECOLAB USA INC. 2002-09-12 US disclosed
EP-0543340-B1 Process for preparing lactones TOSOH CORP (JP) 1998-05-20 EP disclosed
US-5502217-A MULTISTAGE PROCESS WITH HYDROGENATION OF MALEIC ACID OR SUCCINIC ACID IN THE PRESENCE OF METAL TO FORM BUTYROLACTONE TOSOH CORPORATION (JP) 1996-03-26 US disclosed
EP-0543340-A1 Process for preparing lactones Tosoh Corporation (JP) 1993-05-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020128312-A1 Adding a C2 or higher alcohol as a stabilizer ADH1C, ADH1A, PCCA DGKA 534/4885TSHR 4312/4885PAM 3626/4885
US-20030021853-A1 In situ mono-or diester dicarboxylate compositions DDC, HCAR3, ACMSD DGKA 109/4885TSHR 4231/4885PAM 729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.